| Promiscuous and allele-specific anchors in HLA-DR-binding peptides J Hammer, P Valsasnini, K Tolba, D Bolin, J Higelin, B Takacs, ... Cell 74 (1), 197-203, 1993 | 505 | 1993 |
| A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors LE Raez, K Papadopoulos, AD Ricart, EG Chiorean, RS DiPaola, ... Cancer chemotherapy and pharmacology 71, 523-530, 2013 | 491 | 2013 |
| HSV ICP0 recruits USP7 to modulate TLR-mediated innate response S Daubeuf, D Singh, Y Tan, H Liu, HJ Federoff, WJ Bowers, K Tolba Blood, The Journal of the American Society of Hematology 113 (14), 3264-3275, 2009 | 164 | 2009 |
| NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents J Laskin, SV Liu, K Tolba, C Heining, RF Schlenk, P Cheema, J Cadranel, ... Annals of Oncology 31 (12), 1693-1703, 2020 | 86 | 2020 |
| Development of herpes simplex virus-1 amplicon–based immunotherapy for chronic lymphocytic leukemia KA Tolba, WJ Bowers, SP Hilchey, MW Halterman, DF Howard, ... Blood, The Journal of the American Society of Hematology 98 (2), 287-295, 2001 | 79 | 2001 |
| Durable response to afatinib in lung adenocarcinoma harboring NRG1 gene fusions ND Gay, Y Wang, C Beadling, A Warrick, T Neff, CL Corless, K Tolba Journal of Thoracic Oncology 12 (8), e107-e110, 2017 | 75 | 2017 |
| Cardiotoxicity of cancer therapy KA Tolba, EN Deliargyris Cancer investigation 17 (6), 408-422, 1999 | 68 | 1999 |
| Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase … HJ Wanebo, J Lee, BA Burtness, JA Ridge, M Ghebremichael, ... Annals of oncology 25 (10), 2036-2041, 2014 | 54 | 2014 |
| Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity KA Tolba, WJ Bowers, J Muller, V Housekneckt, RE Giuliano, HJ Federoff, ... Cancer research 62 (22), 6545-6551, 2002 | 45 | 2002 |
| Identification and utilization of biomarkers to predict response to immune checkpoint inhibitors O Gjoerup, CA Brown, JS Ross, RSP Huang, A Schrock, J Creeden, ... The AAPS Journal 22, 1-15, 2020 | 38 | 2020 |
| Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response HM Cho, JD Rosenblatt, K Tolba, SJ Shin, DS Shin, C Calfa, Y Zhang, ... Cancer research 70 (24), 10121-10130, 2010 | 37 | 2010 |
| Therapeutic Potential of Afatinib in NRG1 Fusion‐Driven Solid Tumors: A Case Series J Cadranel, SV Liu, M Duruisseaux, E Branden, Y Goto, BA Weinberg, ... The oncologist 26 (1), 7-16, 2021 | 36 | 2021 |
| Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC) LE Raez, ES Santos, G Lopes, MF Rosado, LM Negret, C Rocha-Lima, ... Lung cancer 53 (3), 347-353, 2006 | 33 | 2006 |
| Phase II induction cetuximab (C225), paclitaxel (P), and carboplatin (C) followed by chemoradiation with C225, P, C, and RT 68-72Gy for stage III/IV head and neck squamous … HJ Wanebo, MS Ghebremichael, B Burtness, JA Ridge, S Spencer, ... Journal of Clinical Oncology 28 (15_suppl), 5513-5513, 2010 | 26 | 2010 |
| HSV amplicon-mediated delivery of LIGHT enhances the antigen-presenting capacity of chronic lymphocytic leukemia KA Tolba, WJ Bowers, DJ Eling, AE Casey, TJ Kipps, HJ Federoff, ... Molecular therapy 6 (4), 455-463, 2002 | 24 | 2002 |
| Clinicopathologic and genomic landscape of non-small cell lung cancer brain metastases RSP Huang, L Harries, B Decker, MC Hiemenz, K Murugesan, J Creeden, ... The Oncologist 27 (10), 839-848, 2022 | 22 | 2022 |
| Efficacy and toxicity of chemoradiotherapy with carboplatin and irinotecan followed by consolidation docetaxel for unresectable stage III non-small cell lung cancer BR Bastos, GF Hatoum, GR Walker, K Tolba, C Takita, J Gomez, ... Journal of thoracic oncology 5 (4), 533-539, 2010 | 21 | 2010 |
| Adoptively Transferred Tumor-Specific T Cells Stimulated Ex vivo Using Herpes Simplex Virus Amplicons Encoding 4-1BBL Persist in the Host and Show Antitumor Activity … KH Yi, H Nechushtan, WJ Bowers, GR Walker, Y Zhang, DG Pham, ... Cancer research 67 (20), 10027-10037, 2007 | 21 | 2007 |
| Complementary roles for tissue-and blood-based comprehensive genomic profiling for detection of actionable driver alterations in advanced NSCLC LS Schwartzberg, G Li, K Tolba, AB Bourla, K Schulze, R Gadgil, A Fine, ... JTO Clinical and Research Reports 3 (9), 100386, 2022 | 17 | 2022 |
| Responses to the combination of the glycolytic inhibitor 2-deoxy-glucose (2DG) and docetaxel (DC) in patients with lung and head and neck (H/N) carcinomas LE Raez, V Langmuir, K Tolba, CM Rocha-Lima, K Papadopoulos, S Kroll, ... Journal of Clinical Oncology 25 (18_suppl), 14025-14025, 2007 | 17 | 2007 |
Howard J FederoffDistinguished Professor of neurology, retired
Howard J FederoffDistinguished Professor of neurology, retired